GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Pramipexole extended-release (MIRAPEX ER)

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Mirapex ER - labeled renal guidance

Product / population
Pramipexole (Mirapex ER), adult once-daily extended-release tablets
Renal method
Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Source revision
Prescribing information revised 6/2024
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

URL name does not establish immediate-release formulation

The /mirapex-drug/ page body reviewed for this import describes MIRAPEX ER.

What to reconcile: Use this entry only for the extended-release product; do not transfer its renal schedule to immediate-release pramipexole.

Source difference identified; final patient-specific adjudication required.

Open this note and its source references

MIRAPEX URL: retrieved body identifies extended release

The generic-looking mirapex URL displays MIRAPEX ER instructions. Its URL title is not sufficient evidence for immediate-release dosing.

What to reconcile: Use this source only within its explicitly identified ER scope. Keep the separate official IR record and RLS instructions distinct.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references

Mirapex ER - product and source limitations

ER use is not recommended below 30 mL/min or on hemodialysis. Confirm the release form before prescribing.

What to reconcile: Verify the current prescribing information for this presentation.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Mirapex ER - labeled renal guidance

Open original reference

FDA / product prescribing information · Pramipexole (Mirapex ER), adult once-daily extended-release tablets

Renal method: Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Source date: Prescribing information revised 6/2024
Retrieved: 2026-11-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Dialysis evidence: Use is not recommended / excluded in the named dialysis population; not a dialysis dose

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 2, renal impairment

At CrCl 30-50 mL/min, start with 0.375 mg every other day. After one week, consider daily dosing according to response and tolerance. Further increases are by 0.375 mg at intervals of at least one week, up to 2.25 mg/day. ER use is not recommended below 30 mL/min or on hemodialysis. Confirm the release form before prescribing.

RDM73-mirapex-er-official-1 · Source locator: Renal guidance: 2, renal impairment

Source identity and provenance
Source family
product_label
Source
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022421s023lbl.pdf
Retrieved
2026-11-07
Renal-function method
Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Source date/version
Prescribing information revised 6/2024
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
6a5d30e9cb661a5b0d1a1e9941387a6da0ef1fe3022a693a72a273e3bbe2fa85

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=pramipexole-mirapex-er&s1=RDM73-mirapex-er-official&h1=3619681f4aa96e256991c34fa548fe19dd4c27961a1cd6a95e21f8263639afcf

Top